Angela Morehead – Cervical Cancer Screening and Management Update

*** Proof of Product ***

---

Exploring the Essential Features of “Angela Morehead – Cervical Cancer Screening and Management Update”

Speaker: Angela Morehead, DNP, FNP, C-EFM

Duration: 1 Hour 04 Minutes

Format: Audio and Video

Copyright: Aug 01, 2023  

Media Type: Digital Seminar

Description

Providers who care for women should be aware of the most recent changes to cervical cancer screening guidelines. It is not difficult to determine the plan for screening if the provider is aware of the management algorithm. However, if a clinician is not routinely doing women’s health care the changes can be confusing, and the module will enable the provider to be confident in their plan of care for cervical cancer screening and abnormality management. The changes can be very confusing and concerning for patients who are unaware, and this module can help the clinician to educate their patients regarding the updates. 

Speaker

Angela Morehead, DNP, FNP, C-EFM

Angela Morehead, DNP, FNP, C-EFM, is a family nurse practitioner with over 15 years as a women’s healthcare provider. She is the research director for Avana Health and is adjunct faculty at Franklin University. She received her BSN and MSN from Middle Tennessee State University, and her DNP from Belmont University. Dr. Morehead has cared for patients in both inpatient and outpatient settings and has taught nursing students at the undergraduate and graduate level. She currently serves on the Tennessee Maternal Mortality Review Committee, the National Association for Nurse Practitioners in Women’s Health Competency Committee, and has published and presented on a variety of women’s health topics.

Speaker Disclosures:
Financial: Angela Morehead has employment relationships with Avana Health and IVX Health. She receives a speaking honorarium from Organon. Angela Morehead receives a speaking honorarium from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Angela Morehead serves on the Tennessee Maternal Mortality review committee.

Objectives

1. Identify the types of cell abnormalities that can occur on cervical cytology.
2. Discuss the components of the Bethesda classification. 
3. Identify available resources to assist in determining necessity of screening based on age and screening history, and to outline an appropriate plan of care based on screening results. 

Outline

Cervical cancer stats

• Incidence
• Survival rates

Risk factors for cervical cancer

• Age
• Medical history
• Environmental factors
• Access to care – demographic factors

Discussion of pap smear

• What is a pap test?
• Types of preparation
• Discussion of types of cells in the cervix

Bethesda classification, abnormality type (ASCUS, ASC-H, LSIL, HSIL, AGC)
ASCCP guidelines for screening 
Clinical considerations 
Management of abnormal results – algorithm
Case studies for management of abnormal results
Prevention – HPV vaccine
Commonly asked questions regarding pap test and HPV vaccine

Target Audience

• Nurses
• Nurse Practitioners
• Clinical Nurse Specialists
• Physician Assistants

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/